Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients have higher oxidative stress and lower antioxidant levels.

Topical calcipotriol may help treat alopecia areata, especially in those with low vitamin D.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Zinc supplementation may be an important part of treating severe hair loss.

Patients with Type 1 diabetes should be screened for pernicious anemia.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

People with Alopecia Areata often have lower vitamin D levels, and vitamin D supplements might help treat it.

Toxic metals can cause hair loss and should be considered by doctors.

Too much epidermal growth factor can cause hair loss.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Alopecia areata may be linked to heart issues.

People with alopecia areata often have lower vitamin D levels than healthy people.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Low levels of zinc and ferritin may be linked to the severity of alopecia areata in Iraqi patients.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Treating ovarian-related inflammation may help hair regrowth in women with alopecia areata.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.

Alopecia areata may be caused by the immune system attacking hair follicles.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Oxidative stress is linked to mild patchy alopecia areata.

Higher RBP4 levels found in people with two types of hair loss.